- Motley Fool•yesterday
Cancer drug costs routinely eclipse the six-figure mark, but the prices of these cancer drugs are truly eye-popping.
- Zacks•4 days ago
Shire plc (SHPG) announced that the FDA has acknowledged receipt of the Class 2 resubmission of a New Drug Application (NDA) for pipeline candidate, SHP465.
- Reuters•4 days ago
Leaders of the global pharmaceutical industry, blasted by incoming U.S. President Donald Trump for "getting away with murder" on drug prices, are putting a brave face on the challenges in their biggest market.
SHP.L: Summary for SHIRE PLC ORD 5P - Yahoo Finance
Shire plc (SHP.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
|Bid||4,315.00 x 51000|
|Ask||4,395.00 x 53800|
|Day's range||4,307.75 - 4,394.50|
|52-week range||2,707.19 - 5,377.00|
|PE ratio (TTM)||200.28|
|Dividend & yield||0.26 (0.48%)|
|1y target est||N/A|